| Product No | EMEA/H/C/000389 |
|---|---|
| Brand Name | Invanz |
| Nonproprietary Name | ertapenem |
| API | ertapenem sodium |
| ATC Code | J01DH03 |
| Indications | TreatmentTreatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required:intra-abdominal infections;community-acquired pneumonia;acute gynaecological infections;diabetic foot infections of the skin and soft tissue.PreventionInvanz is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery.Consideration should be given to official guidance on the appropriate use of antibacterial agents. |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Merck Sharp & Dohme B.V. |
| Status | Authorised(授权) |
| Authorization Date | 2002-04-18 |
| Version | 26 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information